Trials / Completed
CompletedNCT00885300
Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Shiraz University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate whether cloxacillin lock is effective in prevention of double lumen infection.
Detailed description
Double lumen infection is one of the causes of morbidity and mortality in hemodialysis patients. Many strategies used to prevent it and one of them is antibiotic lock. Thus we select chronic hemodialysis patients and divided them into 2 groups. One group received cloxacillin and heparin as catheter lock and the second group received only heparin lock.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cloxacillin | cloxacillin 100mg/ml as catheter lock at the end of hemodialysis |
| DRUG | heparin | heparin 1000iu/ml as catheter lock at the end of hemodialysis |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-07-01
- Completion
- 2008-09-01
- First posted
- 2009-04-21
- Last updated
- 2009-04-21
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00885300. Inclusion in this directory is not an endorsement.